Funding · Healthcare & Life Sciences

Elevate Now raises ₹18 crore seed round led by Physis Capital

By Startup Enthusiast · 4 February 2026

What they do

Elevate Now offers subscription-based online weight loss programs with personalized support and GLP-1 drugs

The company raised ₹18 crore in seed funding to strengthen its technology stack and expand clinical research capabilities

With over 30,000 paid users and strong monthly growth, it competes in India's projected $100 billion anti-obesity market

Elevate Now has raised ₹18 crore (approximately $2 million) in a seed funding round.
Physis Capital led the investment round for the health-tech startup.
Inflection Point Ventures and Titan Capital participated in the funding round.
The company plans to use the funds to strengthen its tech stack and develop nutritional supplements.
Elevate Now aims to expand its clinical research and build personalization systems using the new capital.
Suryansh Kumar founded Elevate Now after working as an executive at Swiggy.
The startup currently serves more than 30,000 paid users across its platform.
Revenue grew by an average of 17% month-on-month between April 2025 and January 2026.

Elevate Now operates in a sector where the India anti-obesity drugs market is projected to reach $100 billion by 2030.
The company faces competition from established players like Healthify and HealthifyRx.
This funding follows a previous raise of $1.8 million from W Health Ventures and Narayana Health.
The investment highlights growing interest in medically-assisted weight loss solutions in India.

Elevate Now provides subscription-led online weight management programmes to its customers.
The platform offers personalized support and therapies for weight loss goals.
Users receive guidance on nutrition, fitness, and stress management through the service.
Elevate Now prescribes GLP-1 drugs for medically-assisted weight loss under supervision.
The business model relies on recurring revenue from user subscriptions.
The company focuses on building a robust tech stack to support its services.
Elevate Now integrates clinical research into its core operational framework.
The startup targets individuals seeking structured and medically supervised weight loss journeys.
It competes directly with other digital health platforms offering similar weight management tools.

Elevate Now will strengthen its technology infrastructure to improve user experience.
The company plans to develop new nutritional supplement products for its users.
Elevate Now intends to expand its clinical research capabilities significantly.
The startup aims to build advanced personalization systems for better health outcomes.

Physis Capital (lead) — Venture capital firm leading the seed round for Elevate Now.
Inflection Point Ventures (participated) — Investment firm participating in the seed funding round.
Titan Capital (participated) — Investment firm participating in the seed funding round.

Product: Online clinical weight loss programme with personalized nutrition, fitness, and therapy guidance.
Customers: Individuals with obesity or metabolic conditions seeking sustainable weight loss.
How it makes money: Subscription-based online weight management programmes.
What sets it apart: Doctor-led, root-cause-driven approach with proprietary clinical research and personalization systems.